Jabrzyk, M. et al. 2026. The Role and Efficacy of Rifaximin in the Treatment of Irritable Bowel Syndrome - Based on current research in 2026. Quality in Sport. 53, (Mar. 2026), 70303. DOI:https://doi.org/10.12775/QS.2026.53.70303.